Abnormal metabolism is a key tumor hallmark. Proton magnetic resonance spectroscopy (1H-MRS) allows measurement of metabolite concentration that can be utilized to characterize tumor metabolic changes. 1H-MRS measurements of specific metabolites have been implemented in the clinic.
Dr John Gauvin (DSM, Holland) recently gave an excellent webinar presentation where he compared the errors and accuracy that can be expected when either “sum” or “peaks” (GSD) integration is used
NMR binding assays are routinely applied in hit finding and validation during early stages of drug discovery, particularly for fragment-based lead generation. To this end, compound libraries are screened by ligand-observed NMR experiments such as STD, T1ρ, and CPMG to identify molecules interacting with a target.
John Gauvin, Assistant NMR Scientist at DSM, Netherlands, gave a free webinar about a statistical comparison made on several quantification techniques using Mnova NMR software.
The authors describe methods to quickly acquire NUS-assisted 2D spectra that are suitable for qNMR.